Your browser doesn't support javascript.
loading
Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer.
Kim, Ji Won; Luck, Cuyler; Wu, Wei; Ponce, Rovingaile Kriska; Lin, Yone Kawe; Gupta, Nehal; Okimoto, Ross A.
Afiliación
  • Kim JW; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Jeju Research Institute of Pharmaceutical Sciences, College of Pharmacy, Jeju National University, Jeju, Republic of Korea.
  • Luck C; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Wu W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Ponce RK; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Lin YK; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Gupta N; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Okimoto RA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. Electronic address: ross.okimoto@ucsf.edu.
Cell Rep ; 41(1): 111443, 2022 10 04.
Article en En | MEDLINE | ID: mdl-36198276

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Represoras / Neoplasias Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Represoras / Neoplasias Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos